Related Experiment Videos
Decreased nitric oxide production in primary open-angle glaucoma
S Doganay1, C Evereklioglu, Y Turkoz
1Department of Ophthalmology, Inönü University Medical Faculty, Turgut Ozal Medical Center, Research Hospital, Malatya, Turkey. sdoganay@inonu.edu.tr
European Journal of Ophthalmology
|April 9, 2002
Summary
Patients with primary open-angle glaucoma (POAG) have significantly lower nitric oxide (NO) levels in their aqueous humor. This suggests NO-producing cells may be lost in POAG, indicating NO levels could be a therapeutic target.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Nitric Oxide Biology
Background:
- Elevated intraocular pressure (IOP) is a primary risk factor for optic nerve damage in primary open-angle glaucoma (POAG).
- The trabecular meshwork regulates aqueous humor outflow and is influenced by nitric oxide (NO).
- NO is synthesized in various tissues, prompting an investigation into its role in the eye.
Purpose of the Study:
- To compare nitric oxide (NO) levels in the aqueous humor of patients with primary open-angle glaucoma (POAG) versus those with cataracts.
- To investigate the potential link between NO production and the progression of POAG.
Main Methods:
- Aqueous humor samples were collected from 16 POAG patients and 14 age/sex-matched cataract controls during surgery.
- Total nitrite levels, an indicator of NO, were measured using the Greiss reaction.
- Statistical analysis was performed using the Mann-Whitney U test (P <0.05 significance).
Main Results:
- Mean aqueous humor NO levels were significantly lower in POAG patients (72.72±11.21 µmol/L) compared to cataract controls (86.92±11.23 µmol/L).
- The difference in NO levels between the two groups was statistically significant (P = 0.001).
Conclusions:
- Reduced NO production in POAG patients suggests a potential loss of NO-producing cells as the disease advances.
- Modulating NO levels in the eye may represent a viable therapeutic strategy for managing glaucoma.